TRICARE West Expands NeuroStar TMS Coverage To Include Adolescents Aged 15+ Struggling With Depression

Neuronetics, Inc., a medical technology company that designed and markets NeuroStar Advanced Therapy, which provides transcranial magnetic stimulation (TMS), announced that TriWest, the regional administrator for TRICARE, has updated its medical policy to include TMS coverage for adolescents aged 15 and older diagnosed with major depressive disorder (MDD). TRICARE coverage is primarily used by active and retired military service members and their eligible family members. This policy update, effective immediately, applies to TRICARE beneficiaries in these states: Alaska, Arizona, Arkansas, California, Colorado, Hawaii, Idaho, Illinois, Iowa, Kansas, Louisiana, Minnesota, Missouri, Montana, Nebraska, Nevada, New Mexico, North Dakota, Oklahoma, Oregon, South . . .